» Authors » Adam C Parslow

Adam C Parslow

Explore the profile of Adam C Parslow including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 23
Citations 370
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Chen Y, Wijekoon S, Matsumoto A, Luo J, Kiriazis H, Masterman E, et al.
Clin Sci (Lond) . 2024 Jul; 138(15):941-962. PMID: 39018488
Atrial fibrillation (AF) remains challenging to prevent and treat. A key feature of AF is atrial enlargement. However, not all atrial enlargement progresses to AF. Atrial enlargement in response to...
2.
Janes P, Parslow A, Cao D, Rigopoulos A, Lee F, Gong S, et al.
Cancers (Basel) . 2024 May; 16(10). PMID: 38791979
The vascular endothelial growth factors (VEGFs) and their receptors (VEGFRs) are key regulators of blood vessel formation, including in tumors, where their deregulated function can promote the production of aberrant,...
3.
Schmied C, Nelson M, Avilov S, Bakker G, Bertocchi C, Bischof J, et al.
Nat Methods . 2023 Sep; 21(2):170-181. PMID: 37710020
Images document scientific discoveries and are prevalent in modern biomedical research. Microscopy imaging in particular is currently undergoing rapid technological advancements. However, for scientists wishing to publish obtained images and...
4.
Schmied C, Nelson M, Avilov S, Bakker G, Bertocchi C, Bischof J, et al.
ArXiv . 2023 Feb; PMID: 36824427
Images document scientific discoveries and are prevalent in modern biomedical research. Microscopy imaging in particular is currently undergoing rapid technological advancements. However for scientists wishing to publish the obtained images...
5.
Farrugia G, McLellan M, Weeks K, Matsumoto A, Cohen C, Krstevski C, et al.
STAR Protoc . 2021 Oct; 2(4):100866. PMID: 34647038
This protocol features parallel isolation of myocytes and non-myocytes from murine hearts. It was designed with considerations for (1) time required to extract cardiac cells, (2) cell viability, and (3)...
6.
Berthelet J, Wimmer V, Whitfield H, Serrano A, Boudier T, Mangiola S, et al.
Sci Adv . 2021 Jul; 7(28). PMID: 34233875
Intratumoral heterogeneity is a driver of breast cancer progression, but the nature of the clonal interactive network involved in this process remains unclear. Here, we optimized the use of optical...
7.
Huynh J, Baloyan D, Chisanga D, Shi W, OBrien M, Afshar-Sterle S, et al.
Cancer Immunol Res . 2021 Apr; 9(7):735-747. PMID: 33906864
IL11 is a member of the IL6 family of cytokines and signals through its cognate receptor subunits, IL11RA and glycoprotein 130 (GP130), to elicit biological responses via the JAK/STAT signaling...
8.
Hafeez U, Parslow A, Gan H, Scott A
Expert Rev Anticancer Ther . 2020 Sep; 20(12):1057-1074. PMID: 32981377
Introduction: The importance of ErbB3 receptor tyrosine kinase in cancer progression, primary and acquired drug resistance, has become steadily evident since its discovery in 1989. ErbB3 overexpression in various solid...
9.
Wichmann C, Goh Y, Parslow A, Rigopoulos A, Guo N, Scott A, et al.
EJNMMI Radiopharm Chem . 2020 Jan; 5(1):3. PMID: 31974638
Background: Targeted therapy of HER2 positive breast cancer has led to clinical success in some cases with primary and secondary resistance being major obstacles. Due to the substantial involvement of...
10.
Thilakasiri P, Huynh J, Poh A, Tan C, Nero T, Tran K, et al.
EMBO Mol Med . 2019 Mar; 11(4). PMID: 30885958
Excessive signaling through gp130, the shared receptor for the interleukin (IL)6 family of cytokines, is a common hallmark in solid malignancies and promotes their progression. Here, we established the utility...